Dosimetry Study of [131I]ICF01012 in Targeted Radionuclide Therapy of Melanoma

被引：0
|
作者：
Fois, G. [1 ,2 ]
Auzeloux, P. [3 ]
Billoux, T. [4 ]
Cachin, F. [4 ]
Degoul, F. [3 ]
Jouberton, E. [4 ]
Levesque, S. [4 ]
Miot-Noirault, E. [3 ]
Sas, N. [4 ]
Maigne, L. [1 ,2 ]
机构：
[1] Univ Clermont Auvergne, Aubiere 63, France
[2] Lab Phys Clermont, Aubiere, France
[3] INSERM, Clermont Ferrand, France
[4] Ctr Jean Perrin, Clermont Ferrand, France
来源：
MEDICAL PHYSICS | 2020年 / 47卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
PO-GeP-T-3
引用
收藏
页码：E760 / E760
页数：1
相关论文
共 50 条
  • [41] Factors influencing the dosimetry and the therapeutic outcome of 131I therapy of differentiated thyroid cancer (DTC).
    Behr, TM
    Béhé, MP
    Gratz, S
    Hüfner, M
    Becker, W
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 242P - 242P
  • [42] Patient-Specific Dosimetry Using Pretherapy [124I]m-iodobenzylguanidine ([124I]mIBG) Dynamic PET/CT Imaging Before [131I]mIBG Targeted Radionuclide Therapy for Neuroblastoma
    Huang, Shih-ying
    Bolch, Wesley E.
    Lee, Choonsik
    Van Brocklin, Henry F.
    Pampaloni, Miguel H.
    Hawkins, Randall A.
    Sznewajs, Aimee
    DuBois, Steven G.
    Matthay, Katherine K.
    Seo, Youngho
    MOLECULAR IMAGING AND BIOLOGY, 2015, 17 (02) : 284 - 294
  • [43] Patient-Specific Dosimetry Using Pretherapy [124I]m-iodobenzylguanidine ([124I]mIBG) Dynamic PET/CT Imaging Before [131I]mIBG Targeted Radionuclide Therapy for Neuroblastoma
    Shih-ying Huang
    Wesley E. Bolch
    Choonsik Lee
    Henry F. Van Brocklin
    Miguel H. Pampaloni
    Randall A. Hawkins
    Aimee Sznewajs
    Steven G. DuBois
    Katherine K. Matthay
    Youngho Seo
    Molecular Imaging and Biology, 2015, 17 : 284 - 294
  • [44] Are chromosome aberrationss reliable as biological dosimetry in thyroid cancer patients after 131I therapy?
    Lu, HK
    Zhu, RS
    Yu, YL
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 322P - 322P
  • [45] Monte Carlo simulations of novel optical imaging methods for 131I radiometabolic therapy dosimetry
    Loi, S.
    Cattaneo, M.
    Spinelli, A. E.
    JOURNAL OF INSTRUMENTATION, 2019, 14 (07)
  • [46] Multicellular dosimetry in voxel geometry for targeted radionuclide therapy
    Malaroda, A
    Flux, GD
    Buffa, FM
    Ott, RJ
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2003, 18 (03) : 451 - 461
  • [47] Accurate dosimetry in 131I radionuclide therapy using patient-specific, 3-dimensional methods for SPECT reconstruction and absorbed dose calculation
    Dewaraja, YK
    Wilderman, SJ
    Ljungberg, M
    Koral, KF
    Zasadny, K
    Kaminiski, MS
    JOURNAL OF NUCLEAR MEDICINE, 2005, 46 (05) : 840 - 849
  • [48] Virtual CT for Improved Targeted Radionuclide Therapy Dosimetry
    Mok, G. S.
    Li, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S411 - S412
  • [49] The Impact of PET and SPECT on Dosimetry for Targeted Radionuclide Therapy
    Flux, Glenn
    Bardies, Manuel
    Monsieurs, Myriam
    Savolainen, Sauli
    Strand, Sven-Erik
    Lassmann, Michael
    ZEITSCHRIFT FUR MEDIZINISCHE PHYSIK, 2006, 16 (01): : 47 - 59
  • [50] Overview of dosimetry for systemic targeted radionuclide therapy (STaRT)
    Wessels, Barry W.
    Syh, Joseph H.
    Meredith, Ruby F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (02): : S39 - S45
12345